Biodimension

Develops human-relevant, lab-grown tissue and organoid models and platforms for pharmaceutical, biotech, and cosmetic research. The company builds 3D tumour microenvironment models and skin model suites, provides bioassay-as-a-service and biobank capabilities, and focuses on replacing or reducing reliance on animal testing by delivering more predictive, human-relevant data to improve decision-making in preclinical research, safety testing and product development.